Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and safety of Andrographis paniculata extract in patients with mild COVID-19
TCTR20210708001Phase 2Completed
- Sponsor
- Thai Traditional Medicine Knowledge Fund
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of andrographis paniculata extract in coronavirus disease 2019 (COVID-19), sponsored by Thai Traditional Medicine Knowledge Fund. Started Nov 2020; status: completed.
02
Drugs
andrographis paniculata extract
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20210708001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210708001.